What Is Rytary? Uses, Dosage, and What You Need to Know in 2026

Rytary is a prescription medication used to treat Parkinson's disease. If you or a loved one has recently been prescribed Rytary — or is considering it — this guide explains what Rytary is, what it does, how it's taken, and the key facts every patient should know going into 2026.

What Is Rytary?

Rytary is the brand name for carbidopa and levodopa extended-release capsules, made by Amneal Pharmaceuticals. It was approved by the FDA in January 2015 for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism caused by carbon monoxide or manganese poisoning.

You may see it searched as 'Rytary XR' or 'Rytary extended release,' but the official brand name is simply Rytary. The 'extended release' refers to how the capsule is designed to slowly release the medication into your body over time, providing more consistent symptom control throughout the day than immediate-release carbidopa-levodopa (Sinemet).

What Is Rytary Used For?

Rytary is FDA-approved for the following conditions:

Parkinson's disease — The primary indication. Parkinson's disease is a progressive neurological condition where dopamine-producing brain cells die off, causing symptoms like tremors, stiffness, slowness of movement, and balance problems.

Post-encephalitic parkinsonism — Parkinson-like symptoms resulting from a past brain infection (encephalitis).

Toxic parkinsonism — Parkinson-like symptoms caused by carbon monoxide or manganese poisoning.

Rytary is particularly well-suited for patients with moderate to advanced Parkinson's who experience 'wearing off' — where symptoms return before the next dose is due — because its extended-release formulation provides more consistent levodopa levels in the blood and brain throughout the day.

What Are the Rytary Dosage Strengths?

Rytary comes in four extended-release capsule strengths, each containing carbidopa and levodopa:

23.75 mg/95 mg (blue and white capsule, marked "95")

36.25 mg/145 mg (blue and yellow capsule, marked "145")

48.75 mg/195 mg (blue and yellow capsule, marked "195")

61.25 mg/245 mg (blue capsule, marked "245")

Many patients are prescribed a combination of different strengths to achieve their optimal daily levodopa dose. Your neurologist will calculate this using a conversion table from the Rytary prescribing information.

How to Take Rytary

Swallow whole. Do not chew, crush, or divide Rytary capsules. If you have difficulty swallowing, you may carefully open the capsule and sprinkle the entire contents on 1–2 tablespoons of applesauce and consume immediately. Do not store the mixture.

With or without food. Rytary can be taken with or without food. However, a high-fat, high-calorie meal delays levodopa absorption by up to 2 hours. It's usually best to take your first dose of the day 1–2 hours before eating.

Frequency. Typically 3 times daily, up to a maximum of 5 times daily if needed.

Don't stop without guidance. Abrupt discontinuation of Rytary can cause neuroleptic malignant syndrome (NMS), a serious withdrawal reaction. Always taper under medical supervision.

Is Rytary a Controlled Substance?

No. Rytary is not a DEA-scheduled controlled substance. It does not have abuse potential and is not subject to the prescribing restrictions, quantity limits, or refill restrictions that apply to controlled substances like Schedule II stimulants or opioids. This means it can be prescribed via telehealth, can have refills authorized on the prescription, and does not require in-person visits solely due to controlled substance rules.

Is There a Generic Version of Rytary?

No. As of 2026, there is no FDA-approved generic version of Rytary. Rytary uses a proprietary multi-bead capsule technology (IPX066) that is distinct from standard generic carbidopa-levodopa ER tablets. Generic carbidopa-levodopa ER tablets exist, but they have different pharmacokinetics and are not dose-interchangeable with Rytary without a neurologist-guided conversion.

What Does Rytary Cost?

Rytary's retail price is $800–$1,500 per month without insurance. With a discount coupon (GoodRx, SingleCare), 90 capsules can be purchased for approximately $330–$480 depending on strength. Commercially insured patients who enroll in the Amneal/PhilRx savings card may pay as little as $0–$20 per month. Medicare patients should check their specific Part D plan. See our complete guide on how to save money on Rytary for all available options.

Key Takeaways

Rytary is carbidopa and levodopa in an extended-release capsule, approved for Parkinson's disease

Available in 4 strengths; many patients use multiple strengths per dose

Not a controlled substance; can be prescribed via telehealth

No generic available as of 2026; significant savings programs exist for eligible patients

Rytary is not routinely stocked at most retail pharmacies; advance ordering is usually required